Your search for comorbidities returned 3 results

Study finds that the use of a digital therapeutics platform in people with obesity and metabolic syndrome can lead to a reduction in both weight and body mass index.

Significant improvements to the management of metabolic syndrome after liver transplantation must be made to reduce the risk for CV events and mortality.

Glucose-lowering medications and high-intensity statins are not being used sufficiently among high-risk individuals with atherosclerotic cardiovascular disease and diabetes.